HiFiBiO Therapeutics
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
Tech Stack (20 technologies)
Frequently Asked Questions
What technologies does HiFiBiO Therapeutics use?+
HiFiBiO Therapeutics uses 20 technologies including Google Analytics, Google Tag Manager, Modernizr.
What industry is HiFiBiO Therapeutics in?+
HiFiBiO Therapeutics operates in the Biopharma industry.
Where is HiFiBiO Therapeutics based?+
HiFiBiO Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026